Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2021.08.016
Abstract: Background Tocilizumab is a monoclonal antibody that interrupts interleukin-6 signaling, reducing downstream effects on inflammation and the innate immune response. It was shown to reduce mortality in patients with severe or critical COVID-19. Pregnant and… read more here.
Keywords: tocilizumab pregnancy; data tocilizumab; pregnancy; pregnancy lactation ... See more keywords